AMSFAMERISAFE, Inc.
Is the price fair?
In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In its normal range: P/E 10.0 vs a 11.3 median over 41 quarters (−12% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What AMSF's price assumes
AMERISAFE, Inc. trades at 9.97× earnings against 8.86× for the median Insurance - Specialty name, more expensive than its own group.
Trailing P/E · Insurance - Specialty median 8.86 · 1.13× the median: the market pays up for this one
Details›
- Financial Services median P/E625 names
- 12.2
- Insurance - Specialty median P/E14 names
- 8.86
- Market capitalisation
- $463M
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $20.82 |
| Its own P/E history, median | $28.02 |
| Its own P/E history, upper quartile | $32.97 |
| 52-week range | $23.27 – $39.63 |
| Today | $24.74 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Insurance, Specialty
The closest names by size in the same industry